MedPath

ZIONEXA

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

[18F] LBT-999 PET Compared to [123I]-FP/CIT SPECT to Distinguish Between Parkinson's Diseases and Essential Tremor

Phase 3
Recruiting
Conditions
Parkinson Disease
Essential Tremor
Interventions
Drug: SPECT
Drug: PET
First Posted Date
2020-02-11
Last Posted Date
2024-04-16
Lead Sponsor
Zionexa
Target Recruit Count
152
Registration Number
NCT04265209
Locations
🇫🇷

Hôpital Avicenne, Bobigny, France

🇫🇷

Hôpital Henri Mondor, Créteil, France

🇫🇷

CLCC Georges-François Leclerc C.G.F.L, Dijon, France

and more 13 locations
© Copyright 2025. All Rights Reserved by MedPath